|
|
Article: Cyclacel Conserving Resources - Analyst Blog
- Article from:
- Zacks Investment Research - Analyst Blog
- Article date:
- June 18, 2009
- Author:
CopyrightCopyright 2009 Zacks Investment Research. (Hide copyright information)
|
Cyclacel Conserving Resources - Analyst Blog
CYCC: Focus on Key Programs to Conserve Resources
Cyclacel Pharmaceuticals, Inc.
(
CYCC
) is a clinical-stage company dedicated to the discovery, development, and commercialization of small molecule cell cycle inhibitors for the treatment of cancers and other serious disorders. The company's expertise lies in the area of Cell Cycle Inhibition which is a mechanism-targeted approach for the treatment of cancer and other serious proliferative diseases.
Cyclacel aims to develop novel, cell-cycle-based mechanism-targeted cancer therapies that will stop the growth of cancer cells and will limit the damage caused to normal cells. The company ...